Department of Plastic Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
Thomas E. Starzl Transplantation Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
Front Immunol. 2023 Feb 16;14:1093302. doi: 10.3389/fimmu.2023.1093302. eCollection 2023.
Compelling experimental evidence confirms that the robustness and longevity of mixed chimerism (MC) relies on the persistence and availability of donor-derived hematopoietic stem cell (HSC) niches in recipients. Based on our prior work in rodent vascularized composite allotransplantation (VCA) models, we hypothesize that the vascularized bone components in VCA bearing donor HSC niches, thus may provide a unique biologic opportunity to facilitate stable MC and transplant tolerance. In this study, by utilizing a series of rodent VCA models we demonstrated that donor HSC niches in the vascularized bone facilitate persistent multilineage hematopoietic chimerism in transplant recipients and promote donor-specific tolerance without harsh myeloablation. In addition, the transplanted donor HSC niches in VCA facilitated the donor HSC niches seeding to the recipient bone marrow compartment and contributed to the maintenance and homeostasis of stable MC. Moreover, this study provided evidences that chimeric thymus plays a role in MC-mediated transplant tolerance through a mechanism of thymic central deletion. Mechanistic insights from our study could lead to the use of vascularized donor bone with pre-engrafted HSC niches as a safe, complementary strategy to induce robust and stable MC-mediated tolerance in VCA or solid organ transplantation recipients.
强有力的实验证据证实,混合嵌合体(MC)的稳健性和持久性依赖于受者中供体来源造血干细胞(HSC)龛的持续存在和可用性。基于我们在啮齿动物血管化复合组织同种异体移植(VCA)模型中的先前工作,我们假设 VCA 承载供体 HSC 龛的血管化骨成分可能提供了一个独特的生物学机会,以促进稳定的 MC 和移植耐受。在这项研究中,我们利用一系列啮齿动物 VCA 模型证明,血管化骨中的供体 HSC 龛促进了移植受者中持续的多谱系造血嵌合体,并在没有强烈骨髓清除的情况下促进了供体特异性耐受。此外,VCA 中移植的供体 HSC 龛有助于供体 HSC 龛播种到受者骨髓腔室,并有助于稳定 MC 的维持和稳态。此外,这项研究提供的证据表明,嵌合胸腺通过胸腺中央删除机制在 MC 介导的移植耐受中发挥作用。我们研究中的机制见解可能导致使用带有预先植入 HSC 龛的血管化供骨作为一种安全、互补的策略,以在 VCA 或实体器官移植受者中诱导强大和稳定的 MC 介导的耐受。